HomeCompareSPOZF vs JNJ

SPOZF vs JNJ: Dividend Comparison 2026

SPOZF yields 232.56% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPOZF wins by $293.64M in total portfolio value
10 years
SPOZF
SPOZF
● Live price
232.56%
Share price
$0.86
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$293.67M
Annual income
$159,094,488.39
Full SPOZF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — SPOZF vs JNJ

📍 SPOZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPOZFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPOZF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPOZF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPOZF
Annual income on $10K today (after 15% tax)
$19,767.44/yr
After 10yr DRIP, annual income (after tax)
$135,230,315.13/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, SPOZF beats the other by $135,226,329.14/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPOZF + JNJ for your $10,000?

SPOZF: 50%JNJ: 50%
100% JNJ50/50100% SPOZF
Portfolio after 10yr
$146.85M
Annual income
$79,549,588.89/yr
Blended yield
54.17%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SPOZF
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPOZF buys
0
JNJ buys
0
No recent congressional trades found for SPOZF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPOZFJNJ
Forward yield232.56%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$293.67M$30.3K
Annual income after 10y$159,094,488.39$4,689.40
Total dividends collected$278.92M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SPOZF vs JNJ ($10,000, DRIP)

YearSPOZF PortfolioSPOZF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$33,956$23,255.81$10,592$272.30+$23.4KSPOZF
2$110,134$73,800.94$11,289$357.73+$98.8KSPOZF
3$341,552$223,709.32$12,123$472.89+$329.4KSPOZF
4$1,013,853$648,391.74$13,141$629.86+$1.00MSPOZF
5$2,883,575$1,798,752.11$14,408$846.81+$2.87MSPOZF
6$7,866,701$4,781,276.29$16,021$1,151.60+$7.85MSPOZF
7$20,607,870$12,190,500.18$18,122$1,588.22+$20.59MSPOZF
8$51,895,877$29,845,455.63$20,930$2,228.20+$51.87MSPOZF
9$125,770,153$70,241,564.71$24,792$3,191.91+$125.75MSPOZF
10$293,668,552$159,094,488.39$30,274$4,689.40+$293.64MSPOZF

SPOZF vs JNJ: Complete Analysis 2026

SPOZFStock

Sportech PLC, an operator and technology supplier in the gambling market, owns and operates gaming venues in the State of Connecticut, the United Kingdom. It operates through Sportech Venues and Sportech Digital segments. The Sportech Venues segment manages off-track betting venues. The Sportech Digital segment engages in the provision of lottery software and services, and the operation of a pari-mutuel betting website. Sportech PLC was incorporated in 1979 and is based in Edinburgh, the United Kingdom.

Full SPOZF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this SPOZF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPOZF vs SCHDSPOZF vs JEPISPOZF vs OSPOZF vs KOSPOZF vs MAINSPOZF vs ABBVSPOZF vs MRKSPOZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.